[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 437
Citations 0
Research Letter
July 2016

Acral Lentiginous Histologic Subtype and Sentinel Lymph Node Positivity in Thin Melanoma

Author Affiliations
  • 1Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
  • 2Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
JAMA Dermatol. 2016;152(7):836-837. doi:10.1001/jamadermatol.2016.0875

Recent analysis of mortality from melanoma has shown that thin melanomas account for 20% and 25% of melanoma deaths in Australia and the United States, respectively, despite an overall survival rate of approximately 95% for patients with these cancers.1,2 Sentinel lymph node (SLN) biopsy is routinely recommended in patients with intermediate-thickness melanomas, but its role in thin melanomas (≤1 mm) is less well defined3,4; moreover, factors predictive of SLN positivity in this latter group have been variably reported. To specifically examine the prognostic significance of histologic subtype of thin melanomas for SLN metastasis, we reanalyzed these lesions in a cohort of patients originally created for a previous study of thin melanomas.5

First Page Preview View Large
First page PDF preview
First page PDF preview
×